Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis. | PLoS Pathog | 2025 | 40570045 | PubTator, text mining | PubMed |
| 2-Oxoglutarate Analog-Based Biomolecular Tools for Exploring Structure-Activity Relationships in Nonheme Iron Enzymes. | Chembiochem | 2025 | 40545444 | PubTator, text mining | PubMed |
| Amniotic membrane promotes doxorubicin potency by suppressing SH-SY5Y neuroblastoma cell angiogenesis. | BMC Cancer | 2025 | 40537738 | PubTator, text mining | PubMed |
| Succinate links TCA cycle dysfunction to inflammation by activating HIF-1α signaling in acute kidney injury. | Int Immunopharmacol | 2025 | 40532323 | PubTator, text mining | PubMed |
| Correlations between genetically predicted iron-supplement drug targets and inflammatory bowel disease: A Mendelian randomization study. | Medicine (Baltimore) | 2025 | 40527798 | PubTator, text mining | PubMed |
| Mechanism Analysis of Zuogui and Yougui Pills on Diabetic Nephropathy Through Transcriptional Regulatory Networks of HIF1A and PPARA. | Food Sci Nutr | 2025 | 40417738 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
| InDeepNet: a web platform for predicting functional binding sites in proteins using InDeep. | Nucleic Acids Res | 2025 | 40337922 | PubTator, text mining | PubMed |
| Immunodynamic axis of fibroblast-driven neutrophil infiltration in acute pancreatitis: NF-κB-HIF-1α-CXCL1. | Cell Mol Biol Lett | 2025 | 40335899 | PubTator, text mining | PubMed |
| Comprehensive computational strategies for multi-target drug discovery in inflammatory bowel disease utilizing bioactive compounds. | Sci Rep | 2025 | 40319156 | PubTator, text mining | PubMed |
| Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase. | J Med Chem | 2025 | 40263713 | PubTator, text mining | PubMed |
| TaoHeChengQi Decotion alleviate chronic renal failure via regulation of PHD2/UCP1 and RIPK3/AKT/TGF-β pathway. | Phytomedicine | 2025 | 40112631 | PubTator, text mining | PubMed |
| Genetic Associations with the Susceptibility to High-Altitude Pulmonary Edema in the Japanese Population. | High Alt Med Biol | 2025 | 40094446 | PubTator, text mining | PubMed |
| Discovery of Novel, Potent, Orally Bioavailable and Efficacious, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Hematopoietic Stem Cell Mobilization. | J Med Chem | 2025 | 40047531 | PubTator, text mining | PubMed |
| PHD-2/HIF-1α axis mediates doxorubicin-induced angiogenesis in SH-SY5Y neuroblastoma microenvironment: a potential survival mechanism. | Sci Rep | 2025 | 40032892 | PubTator, text mining | PubMed |
| Prolyl hydroxylase domain enzymes (isoforms 1-3, PHD1-3), but not factor-inhibiting HIF-1 (FIH-1), interact with the IKK complex and attenuate LPS-activated NF-kappa-B. | J Toxicol Sci | 2025 | 40024754 | PubTator, text mining | PubMed |
| L-Theanine Mitigates Acute Alcoholic Intestinal Injury by Activating the HIF-1 Signaling Pathway to Regulate the TLR4/NF-κB/HIF-1α Axis in Mice. | Nutrients | 2025 | 40005048 | PubTator, text mining | PubMed |
| Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2. | Redox Biol | 2025 | 39978304 | PubTator, text mining | PubMed |
| β-Hydroxybutyrate Facilitates Postinfarction Cardiac Repair via Targeting PHD2. | Circ Res | 2025 | 39957619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=7